Phar Vision Advisers, LLC Organogenesis Holdings Inc. Transaction History
Phar Vision Advisers, LLC
- $178 Billion
- Q3 2025
A detailed history of Phar Vision Advisers, LLC transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Phar Vision Advisers, LLC holds 36,701 shares of ORGO stock, worth $166,255. This represents 0.09% of its overall portfolio holdings.
Number of Shares
36,701Holding current value
$166,255% of portfolio
0.09%Shares
1 transactions
Others Institutions Holding ORGO
# of Institutions
127Shares Held
69.1MCall Options Held
39.7KPut Options Held
0-
Soleus Capital Management, L.P. Greenwich, CT12.1MShares$55 Million3.34% of portfolio
-
Morgan Stanley New York, NY11.8MShares$53.4 Million0.0% of portfolio
-
First Light Asset Management, LLC Edina, MN7.5MShares$34 Million4.08% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$23 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.04MShares$22.8 Million0.0% of portfolio
About Organogenesis Holdings Inc.
- Ticker ORGO
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 130,888,000
- Market Cap $593M
- Description
- Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...